| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K34485477 |
| PharmacoGx | BRD-K34485477 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CACNG2 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | MAML3 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-05 |
| mRNA | SLC35B4 | CTRPv2 | pan-cancer | AAC | 0.34 | 4e-05 |
| mRNA | NTN3 | CTRPv2 | pan-cancer | AAC | 0.3 | 4e-05 |
| mRNA | NAP1L3 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-05 |
| mRNA | CITED1 | CTRPv2 | pan-cancer | AAC | 0.32 | 5e-05 |
| mRNA | TACR3 | CTRPv2 | pan-cancer | AAC | 2.2 | 6e-05 |
| mRNA | SCN10A | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-05 |
| mRNA | CHRNB3 | CTRPv2 | pan-cancer | AAC | 0.29 | 6e-05 |
| mRNA | MAPK8IP2 | CTRPv2 | pan-cancer | AAC | 0.32 | 6e-05 |
